1993
DOI: 10.1006/bbrc.1993.1651
|View full text |Cite
|
Sign up to set email alerts
|

Induction of in Vitro Tumor Cell Invasion of Cellular Monolayers by Lysophosphatidic Acid or Phospholipase D

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
100
0
4

Year Published

1996
1996
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 171 publications
(110 citation statements)
references
References 0 publications
6
100
0
4
Order By: Relevance
“…We added fibronectin or vitronectin at almost comparable concentrations to those in 1% FBS into the FBS-free assay medium; however, neither of them could stimulate phagokinetic motility of the integrin β3-or HOXD3-transfectants (unpublished data). It is well known that FBS contains several potent motility-stimulating factors, some of which are lysophosphatidic acid (LPA), insulin, epidermal growth factor (EGF), insulin-like growth factor-I (IGF-I), platelet derived growth factor (PDGF), and hepatocyte growth factor (HGF) [27]. LPA, EGF and HGF are unlikely to be a motility-stimulating factor for A549 cells because we have evidence that these molecules do not stimulate the phagokinetic motility of any of the transfectants used here (unpublished data).…”
Section: Hoxd3-transfectants Fibronectin Is a Ligand For A Variety Omentioning
confidence: 99%
“…We added fibronectin or vitronectin at almost comparable concentrations to those in 1% FBS into the FBS-free assay medium; however, neither of them could stimulate phagokinetic motility of the integrin β3-or HOXD3-transfectants (unpublished data). It is well known that FBS contains several potent motility-stimulating factors, some of which are lysophosphatidic acid (LPA), insulin, epidermal growth factor (EGF), insulin-like growth factor-I (IGF-I), platelet derived growth factor (PDGF), and hepatocyte growth factor (HGF) [27]. LPA, EGF and HGF are unlikely to be a motility-stimulating factor for A549 cells because we have evidence that these molecules do not stimulate the phagokinetic motility of any of the transfectants used here (unpublished data).…”
Section: Hoxd3-transfectants Fibronectin Is a Ligand For A Variety Omentioning
confidence: 99%
“…(Imamura et al, 1991), lysophosphatidic acid (Imamura et al, 1993), an unknown factor from rat and bovine livers (invasion inhibiting peptide-2) (Shinkai et al, 1988;Isoai et al, 1990;Isoai et al, 1992) and transmethylation inhibitors modify the capacity of cancer cells to invade mesothelial cell monolayers, but the factors influencing the mesothelial barrier are not well studied. It is generally agreed that transmesothelial penetration by cancer cells occurs at the junctional region between adjacent cells.…”
Section: Ter Measurementsmentioning
confidence: 99%
“…A potential role of LPA and its receptors in the pathogenesis of human cancer, however, is a relatively new concept. LPA was implicated in human tumorigenesis from studies showing that LPA increases the motility and invasiveness of different types of cells (Imamura et al, 1993;Stam et al, 1998). LPA has been shown to be accumulated in ascitic fluids from patients with intraperitoneal malignancies, particularly ovarian cancer and pancreatic cancer (Xu et al, 1995;Westermann et al, 1998;Yamada et al, 2004).…”
Section: Introductionmentioning
confidence: 99%